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January 2005, Herbalife has met and cooperated with 25 regula-
tory agencies, including the Swiss BAG, to address liver-related
case reports and articles in the literature. None of the 25 agencies
has taken any regulatory action affecting Herbalife products.
Most recently, on December 22, 2010, Evira, the food safety
authority in Finland, closed its multi-year inquiry involving
Herbalife case reports, with the agency stating that all require-
ments were satisﬁed, and indicating Herbalife ‘‘acted properly’’
and in ‘‘a thorough manner’’ to ‘‘demonstrate its commitments
to food safety’’.
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JOURNAL OF HEPATOLOGYTo the Editor:
The author’s letter states that the mention of some instances of
herbal medicines is immaterial in the context of the article’s dis-
cussion. We do not agree with this view for the following reasons.
The interest in biomarkers is particularly important for com-
plex herbal medicines and dietary supplements with reports of
hepatotoxicity. Herbalife is one, well illustrated example, which
is supported by at least six peer-review publications [1–6] and a
recent review gathering no less than 30 cases [7]. The causality of
several products sold under the brand name «Herbalife» has
been assessed by using internationally recognized criteria
(WHO score, RUCAM) and has been analysed as certain (positive
rechallenge) or probable in a large number of these cases [1–7].
We appreciate that the manufacturer has made great efforts
to cooperate with health agencies and to produce the safest pos-
sible product.
The fact that the manufacturer did not identify toxic products
does not exclude the role of a particular component or an unex-
pected contaminating product in the overall preparation, particu-
larly when the composition is fairly complex. Furthermore, there
are numerous examples of «classical» drugs associated with very
well documented cases of liver idiosyncratic reactions in a small
proportion of subjects, for which extensive toxicological studies
did not disclose any speciﬁc risk [8]. So, an idiosyncratic reaction
with one of the components of Herbalife is a reasonable
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